Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

antibody-drug conjugates

This page shows the latest antibody-drug conjugates news and features for those working in and with pharma, biotech and healthcare.

‘Excitement’ around new data for Enhertu

‘Excitement’ around new data for Enhertu

and launching the era of targeted drug therapy. ... However, recent developments in the use of antibody-drug conjugates (ADC) involving trastuzumab are offering hope to women with metastatic breast cancer.

Latest news

More from news
Approximately 7 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    Antibody-drug conjugates. New regimes have evolved that help extend the amount of time patients have without their condition worsening. ... One such example is through the development of antibody-drug conjugates (ADC) – monoclonal antibodies attached

  • European biotech: a new generation of leaders emerges European biotech: a new generation of leaders emerges

    it into a drug candidate with commercial potential and taking it all the way to market with strong financing and sound management. ... In addition to traditional antibodies, the pipeline also includes antibody drug conjugates (ADCs), bispecific

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    Current projects include developing antibodies for use as cancer imaging agents, antibody drug conjugates, chimeric antigen receptor therapies (CAR-Ts) and nano-medicines. ... and using efficient AI to generate a set of high-quality drug candidates.

  • Deal Watch February 2016 Deal Watch February 2016

    The antibody, to be known as COR-001, will be progressed for cardiovascular applications. ... This month saw two existing partnerships that have been extended. Takeda has been working with Mersana Therapeutics since 2014 to develop antibody drug

  • Pharma deals in April 2015 Pharma deals in April 2015

    The agreement also includes payment of double digit royalties. Innate also put in place a collaboration with Sanofi for next generation antibody-drug conjugates (ADCs) using Innate's site specific conjugation ... its SAR3419, an antibody-drug conjugate

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

  • Crescendo Biologics appoints Peter Pack as CEO Crescendo Biologics appoints Peter Pack as CEO

    Crescendo is now shifting its focus to oncology with novel VH-based checkpoint modulators and humabody drug conjugate (HDC) therapeutics. ... We intend to expand rapidly our internal oncology programmes on checkpoint modulators and HDCs, which are a

  • ADC Therapeutics expands team ADC Therapeutics expands team

    Appointments preceed its first antibody drug conjugate trials. ADC Therapeutics has significantly expanded its team head of putting its first antibody drug conjugates (ADCs) into clinical development. ... Oncology drug development company's new team

  • ImmunoGen hires VP product strategy ImmunoGen hires VP product strategy

    These programmes focus on antibody-drug conjugates (ADCs) to target cancers. The most successful of these ADCs so far is Kadcyla, which ImmunoGen developed with Genentech, now a part of Roche.

  • AVEO's financial head joins ImmunoGen AVEO's financial head joins ImmunoGen

    In his new role, Johnston will head the financial operations of one of the leading biotechs working to develop antibody-drug conjugates in cancer, with ImmunoGen's successes including the breast

  • CytomX makes senior changes following Pfizer deal CytomX makes senior changes following Pfizer deal

    CytomX Therapeutics has boosted both its senior science and business teams following a major antibody deal with Pfizer. ... Both positions will be crucial to supporting the San Francisco-based biotech's growth following CytomX's  $635m deal agreed with

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
ahair@onyxhealth.com

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....

Quick links